Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has had any discussions with the pharmaceutical companies AstraZeneca and Daiichi Sankyo on offering people living with HER2-low metastatic breast cancer, who are currently unable to access Enhertu due to having received additional lines of chemotherapy, compassionate access to the drug.

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.